Literature DB >> 7858248

Acute promyelocytic leukemia cases with nonreciprocal PML/RARa or RARa/PML fusion genes.

M Lafage-Pochitaloff1, M Alcalay, V Brunel, L Longo, D Sainty, J Simonetti, F Birg, P G Pelicci.   

Abstract

Tumor-associated chromosome translocations usually lead to the formation of two reciprocal fusion genes: one thought to be involved in the transformation process, the other the mechanical consequence of the translocation event. In the case of acute promyelocytic leukemia (APL) blasts, the 15;17 chromosome translocation generates the putatively transforming PML/RARa fusion gene and its reciprocal RARa/PML. We report APL cases with submicroscopic 15;17 recombinations leading to the formation of nonreciprocal PML/RARa or RARa/PML fusion genes. Therefore, each of the two reciprocal translocation products may be independently formed and selected by the leukemic phenotype, implying that both are involved in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7858248

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia.

Authors:  J L Pollock; P Westervelt; A K Kurichety; P G Pelicci; J L Grisolano; T J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  A case of a novel PML/RARA short fusion transcript with truncated transcription variant 2 of the RARA gene.

Authors:  Ivana Jezísková; Filip Rázga; Jana Gazdová; Michael Doubek; Tomás Jurcek; Zdenek Korístek; Jirí Mayer; Dana Dvoráková
Journal:  Mol Diagn Ther       Date:  2010-04-01       Impact factor: 4.074

3.  Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.

Authors:  L Z He; C Tribioli; R Rivi; D Peruzzi; P G Pelicci; V Soares; G Cattoretti; P P Pandolfi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.

Authors:  E M Rego; L Z He; R P Warrell; Z G Wang; P P Pandolfi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

5.  CD79 alpha expression in acute myeloid leukemia. High frequency of expression in acute promyelocytic leukemia.

Authors:  D A Arber; K A Jenkins; M L Slovak
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

6.  Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.

Authors:  John S Welch; Peter Westervelt; Li Ding; David E Larson; Jeffery M Klco; Shashikant Kulkarni; John Wallis; Ken Chen; Jacqueline E Payton; Robert S Fulton; Joelle Veizer; Heather Schmidt; Tammi L Vickery; Sharon Heath; Mark A Watson; Michael H Tomasson; Daniel C Link; Timothy A Graubert; John F DiPersio; Elaine R Mardis; Timothy J Ley; Richard K Wilson
Journal:  JAMA       Date:  2011-04-20       Impact factor: 56.272

7.  High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples.

Authors:  Jacqueline E Payton; Nicole R Grieselhuber; Li-Wei Chang; Mark Murakami; Gary K Geiss; Daniel C Link; Rakesh Nagarajan; Mark A Watson; Timothy J Ley
Journal:  J Clin Invest       Date:  2009-05-18       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.